Univariate factors associated with pre–CAR-T QOL
| Variable . | β (95% CI) . | Standard error . | P value . |
|---|---|---|---|
| Age (y) | 0.54 (0.26-0.82) | 0.14 | < .001 |
| Female sex | −1.48 (−8.61 to 5.65) | 3.59 | .682 |
| Married/with a partner | 6.51(–1.80 to 14.8) | 4.18 | .123 |
| College educated | 7.91 (1.06-14.7) | 3.45 | .024 |
| Income ≥ $100 000 | 7.94 (0.88-15.0) | 3.55 | .028 |
| White race | 6.96 (−3.44 to 17.4) | 5.24 | .187 |
| Bridging therapy use | −8.99 (–16.2 to –1.82) | 3.61 | .015 |
| ECOG performance status | −9.91 (–15.4 to –4.46) | 2.74 | < .001 |
| Diagnosis of lymphoma/leukemia | 3.80 (−3.78 to 11.4) | 3.82 | .322 |
| Months since diagnosis | −0.04 (−0.11 to 0.03) | 0.03 | .236 |
| CAR-T product | |||
| B-cell maturation antigen CAR-T (ref) | Ref | Ref | Ref |
| Tisa-cel | 0.06 (−8.72 to 8.83) | 4.42 | .990 |
| Axi-cel or Brexu-cel | 8.37 (−1.71 to 18.4) | 5.07 | .102 |
| Liso-cel | 6.21 (−4.42 to 16.8) | 5.35 | .249 |
| Variable . | β (95% CI) . | Standard error . | P value . |
|---|---|---|---|
| Age (y) | 0.54 (0.26-0.82) | 0.14 | < .001 |
| Female sex | −1.48 (−8.61 to 5.65) | 3.59 | .682 |
| Married/with a partner | 6.51(–1.80 to 14.8) | 4.18 | .123 |
| College educated | 7.91 (1.06-14.7) | 3.45 | .024 |
| Income ≥ $100 000 | 7.94 (0.88-15.0) | 3.55 | .028 |
| White race | 6.96 (−3.44 to 17.4) | 5.24 | .187 |
| Bridging therapy use | −8.99 (–16.2 to –1.82) | 3.61 | .015 |
| ECOG performance status | −9.91 (–15.4 to –4.46) | 2.74 | < .001 |
| Diagnosis of lymphoma/leukemia | 3.80 (−3.78 to 11.4) | 3.82 | .322 |
| Months since diagnosis | −0.04 (−0.11 to 0.03) | 0.03 | .236 |
| CAR-T product | |||
| B-cell maturation antigen CAR-T (ref) | Ref | Ref | Ref |
| Tisa-cel | 0.06 (−8.72 to 8.83) | 4.42 | .990 |
| Axi-cel or Brexu-cel | 8.37 (−1.71 to 18.4) | 5.07 | .102 |
| Liso-cel | 6.21 (−4.42 to 16.8) | 5.35 | .249 |
Ref., reference.
β-weights indicate differences in FACT-G QOL score based on each univariate predictor. Bolded values are for those with a P value < 0.05.